Sapacitabine tolerated, efficacious in elderly leukemia patients
The nucleoside analog sapacitabine appears to be “active and tolerable” in elderly patients with acute myeloid leukemia, say authors of a phase II study reported in the Lancet Oncology.
No comments:
Post a Comment